Dr. Matthew Frank, MD, PhD, is an Assistant Professor of Medicine in the Division of Blood and Marrow Transplantation and Cellular Therapy at Stanford University. Dr. Frank predominantly cares for patients with high-risk lymphoma and other blood cancers. He is a lead investigator of clinical trials evaluating the safety and effectiveness of CAR T cell therapy for patients with lymphomas and leukemias.  Dr. Frank’s research focuses on developing methods to identify patients who are at high risk for relapse or developing side effects after receiving CAR T therapy and to understand why these relapses and side effects occur.